Skip to main content
Veterinary Medicines

Sedan, 35mg/ml, Oral gel

Authorised
  • Acepromazine

Product identification

Medicine name:
Sedan, 35mg/ml, Oral gel
Sedan 35 mg/ml gel voor oraal gebruik voor paarden en honden
Active substance:
  • Acepromazine
Target species:
  • Horse
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Acepromazine
    35.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral gel
Withdrawal period by route of administration:
  • Oral use
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN05AA04
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Plastic Applicator 1 x 10.0 millilitre(s)
  • Plastic Applicator 1 x 1.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 129523
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0174/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/08/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."